Search Results 241-250 of 16057 for pharmacogenetics
Dr. Chandra's laboratory is developing a practical therapeutic intervention to mitigate osteoporosis induced by hormone depletion, aging or radiotherapy by ...
But trastuzumab does not stop tumors from returning in about 25 percent of patients — and oncologists haven't been able to identify these women before treatment ...
Aim 2 (Biomarkers). To identify and characterize clinical, histological, molecular, and genetic biomarkers that are linked to glomerular disease, disease ...
Application process for the Laboratory Genetics and Genomics Fellowship at Mayo Clinic School of Graduate Medical Education in Rochester, Minnesota.
JACKSONVILLE, Fla. — Researchers at Mayo Clinic have identified a genetic promoter of cancer that drives a major form of lung cancer.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Alogliptin and pioglitazone combination is used with proper diet and exercise to treat high blood sugar levels caused by type 2 diabetes. Alogliptin helps to ...
The purpose of this study is to see if having different kinds of bacteria genes in breast tissue may be connected to the risk of getting breast cancer.
We found differences in genes responsible for antigen interactions, inflammation and differences in the gene pathways involved between low- and high-vaccine ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.